secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001564590-22-023707
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AbCellera shareholders elect Hansen and Hayden as Class II directors at annual meeting
--------------------------------------------------------------------------------

- Carl G. Hansen re-elected with 140.1M for, 32.2M against; Michael Hayden elected with 147.0M for, 25.3M against.
- KPMG ratified as independent auditor for FY 2022: 202.0M for, 0.4M against, 10.7M abstain.
- Non-binding say-on-pay approved: 167.8M for, 4.4M against, 10.7M abstain.
- Advisory vote favored one-year frequency for future say-on-pay: 171.7M for one year.
- Total outstanding shares: 284.5M; broker non-votes of 30.2M on director and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/0001564590-22-023707-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/abcl-8k_20220615.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-023707

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer